Internal Medicine · Chula Vista, CA
NPI
1205823929
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1400 E Palomar St
Chula Vista, CA, 91913
Phone (858) 499-2707
Groups this clinician bills Medicare through
Medicare paid, 2024
$481K
5,727 services
Medicare patients, 2024
480
Average age 74
Drug cost, 2024
$1.2M
14,203 prescriptions
Company payments, 2025
$65.39
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farschad K Birdjandi was code 99309 (snf e&m), 1,215 times for 313 patients. In total Farschad K Birdjandi billed 5,727 services in 27 codes, and Medicare paid $481K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 1,215 | 313 | $78.16 | $95K |
| 99233 Hospital E&M - Subsequent | Facility | 1,118 | 77 | $87.22 | $98K |
| 99310 SNF E&M | Facility | 963 | 281 | $110.58 | $106K |
| 99497 Care Management/Coordination | Facility | 422 | 300 | $55.49 | $23K |
| 99308 SNF E&M | Facility | 342 | 136 | $48.88 | $17K |
| 99306 SNF E&M | Facility | 290 | 238 | $131.85 | $38K |
| 99349 Home E&M - New and Established | Office | 242 | 99 | $95.40 | $23K |
| G0317 Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi | Facility | 231 | 159 | $22.05 | $5,094 |
| 99315 SNF E&M | Facility | 133 | 130 | $60.69 | $8,071 |
| 99350 Home E&M - New and Established | Office | 113 | 67 | $138.67 | $16K |
| 99223 Hospital E&M - Initial | Facility | 102 | 65 | $127.78 | $13K |
| 99348 Home E&M - New and Established | Office | 102 | 40 | $56.95 | $5,809 |
| 99239 Hospital Discharge Management | Facility | 100 | 66 | $85.47 | $8,547 |
| 99497 Care Management/Coordination | Office | 42 | 34 | $62.30 | $2,617 |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Facility | 40 | 34 | $48.25 | $1,930 |
By year: 2022 $523K for 5,977 services; 2023 $699K for 7,788 services; 2024 $481K for 5,727 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farschad K Birdjandi prescribed most often to Medicare patients was Atorvastatin Calcium, with 687 prescriptions and refills. In total Farschad K Birdjandi wrote 14,203 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 687 | 692 | 143 | $8,022 |
| Eliquis Apixaban | 550 | 550 | 87 | $145K |
| Gabapentin Generic | 504 | 507 | 92 | $12K |
| Levothyroxine Sodium Generic | 471 | 472 | 67 | $4,597 |
| Famotidine Generic | 461 | 466 | 84 | $6,223 |
| Amlodipine Besylate Generic | 351 | 353 | 84 | $2,394 |
| Xarelto Rivaroxaban | 320 | 320 | 24 | $96K |
| Carvedilol Generic | 261 | 263 | 62 | $2,541 |
| Tamsulosin Hcl Generic | 253 | 255 | 58 | $3,812 |
| Quetiapine Fumarate Generic | 233 | 235 | 35 | $6,710 |
| Mirtazapine Generic | 228 | 229 | 60 | $4,341 |
| Furosemide Generic | 223 | 224 | 53 | $1,411 |
| Pantoprazole Sodium Generic | 221 | 222 | 67 | $5,934 |
| Metformin Hcl Generic | 214 | 215 | 46 | $2,343 |
| Ipratropium-Albuterol Ipratropium/Albuterol Sulfate | 210 | 210 | 42 | $5,166 |
Brand drugs: 2,844 claims; generic drugs: 11,291 claims; opioid claims: 89.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farschad K Birdjandi $65.39 ($65.39 in general payments such as food, travel and fees) from 2 companies. The largest payer was UCB, Inc. with $33.82.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.